Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Details)

v3.21.1
Fair Value (Details)
3 Months Ended
Oct. 04, 2019
USD ($)
Apr. 03, 2021
USD ($)
reporting_unit
Mar. 28, 2020
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Number of reporting units impaired | reporting_unit   4  
Right-of-use asset impairment   $ 0 $ 691,000
Aerospace Segment      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Impairment loss   73,700,000  
AeroSat      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Right-of-use asset impairment   700,000  
Diagnosys      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Cash paid to acquire stock $ 7,000,000.0    
Fair value of contingent consideration 2,500,000 $ 2,200,000  
Potential additional earn-out $ 13,000,000.0    
Achievement period 3 years    
Earn-out achievement benchmark $ 72,000,000.0